Incyte Corporation is a company in the U.S. stock market and it is a holding in 158 U.S.-traded ETFs. INCY has around 23.3M shares in the U.S. ETF market. The largest ETF holder of INCY is the Invesco QQQ Trust (QQQ), with approximately 2.42M shares. Investors may also find of interest that the ETF with the largest allocation to INCY stock is VanEck Vectors Biotech ETF (BBH), with a portfolio weight of 4.81%. On average, U.S. ETFs allocate 0.39% of INCY to their portfolios.
Additionally, INCY is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with INCY as a holding is the ARK Genomic Revolution ETF (ARKG), with a return of 58.95%.